V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002133 | 330001197 | 1.62 | 93.7 | Curative (C) | 2016-01-01 | 2016-05-25 | NB Low/Interm risk guidelines Carbo/Etop | 2 | N | 330008064 | NOT MATCHED |
| 330002134 | 330001198 | 1.66 | 110 | Curative (C) | 2013-09-18 | 2013-10-15 | Cisplatin | null | Y | 330008065 | CISPLATIN |
| 330002135 | 330001199 | null | 72 | Curative (C) | 2017-04-07 | 2017-04-28 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330008066 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002136 | 330001200 | 1.67 | 58 | Curative (C) | 2017-02-16 | 2017-03-06 | Cisplatin | 01 | Y | 330008067 | CISPLATIN |
| 330002137 | 330001200 | 1.85 | 68.9 | Curative (C) | null | 2016-12-16 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330008067 | NOT MATCHED |
| 330002138 | 330001200 | 1.66 | 7.7 | Neo-adjuvant (N) | 2013-03-22 | 2013-04-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008067 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002139 | 330001201 | 1.67 | 73.1 | Palliative (P) | 2014-08-01 | 2014-08-01 | Trial Unspecified | 01 | N | 330008074 | TRIAL |
| 330002140 | 330001201 | 1.64 | 13.2 | Curative (C) | 2016-01-12 | 2016-01-15 | Cisplatin | N | Y | 330008074 | CISPLATIN |
| 330002141 | 330001202 | null | 59.1 | null | null | 2014-01-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330008086 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002142 | 330001202 | 1.58 | null | Adjuvant (A) | 2015-12-30 | 2016-01-31 | Cisplatin | N | Y | 330008086 | CISPLATIN |
| 330002143 | 330009588 | null | 47.8 | Curative (C) | 2014-12-10 | 2014-12-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 330008090 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002144 | 330009588 | 1.65 | 58.4 | Curative (C) | null | 2016-05-07 | Cisplatin | 02 | Y | 330008090 | CISPLATIN |
| 330002145 | 330012103 | null | 12.5 | null | 2014-12-26 | 2014-12-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008095 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002146 | 330001203 | 1.6 | 87.7 | Curative (C) | 2015-01-27 | 2015-02-24 | Cisplatin | 02 | Y | 330008096 | CISPLATIN |
| 330002147 | 330001203 | 1.68 | 12.5 | Neo-adjuvant (N) | 2013-11-30 | 2013-12-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008096 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002148 | 330001204 | null | 12.1 | Curative (C) | 2016-05-17 | 2016-05-19 | Trial Unspecified | 01 | N | 330008102 | TRIAL |
| 330002149 | 330001205 | null | 74.8 | Curative (C) | 2013-01-25 | 2013-01-26 | null | N | N | 330008104 | NOT MATCHED |
| 330002150 | 330001206 | 1.68 | 69.1 | Neo-adjuvant (N) | 2013-11-05 | 2013-11-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008107 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002151 | 330001207 | 1.58 | 95.5 | Curative (C) | 2017-11-02 | 2017-11-27 | Cisplatin | N | null | 330008112 | CISPLATIN |
| 330002152 | 330001208 | 1.39 | 58.85 | null | 2013-11-07 | 2013-11-18 | Trial Unspecified | Y | N | 330008113 | TRIAL |
| 330002153 | 330001208 | null | null | Palliative (P) | 2016-05-10 | 2016-05-11 | Trial Unspecified | Y | N | 330008113 | TRIAL |
| 330002154 | 330001208 | null | 60.6 | Curative (C) | 2015-10-02 | 2015-10-03 | OST Euramos 1 Closed Trial - Ai | N | N | 330008113 | NOT MATCHED |
| 330002155 | 330001209 | 1.6 | null | Curative (C) | 2014-11-06 | 2014-11-19 | Cisplatin | N | Y | 330008122 | CISPLATIN |
| 330002156 | 330001209 | 0 | 79 | Curative (C) | 2013-10-08 | 2013-10-15 | EW EuroEwing 2012 Arm B VDC | Y | Y | 330008122 | TRIAL |
| 330002157 | 330001209 | 1.89 | 99 | Palliative (P) | 2018-01-28 | 2018-01-28 | Trial Unspecified | N | N | 330008122 | TRIAL |
| 330002158 | 330001209 | 1.63 | 48.8 | Curative (C) | 2014-12-09 | 2015-01-07 | Cisplatin | N | Y | 330008122 | CISPLATIN |
| 330002159 | 330001210 | null | null | null | 2013-10-31 | 2013-11-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330008129 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002160 | 330001211 | 1.7 | 78.6 | Curative (C) | 2014-01-08 | 2014-01-12 | Cisplatin 7 day | null | Y | 330008130 | CISPLATIN |
| 330002161 | 330006654 | 1.46 | 93.7 | Curative (C) | 2013-11-26 | 2013-12-09 | Cisplatin | null | null | 330008131 | CISPLATIN |
| 330002162 | 330001212 | 1.66 | 69 | Curative (C) | 2014-04-19 | 2014-05-12 | Cisplatin | N | Y | 330008132 | CISPLATIN |
| 330002163 | 330001213 | null | 94.2 | Neo-adjuvant (N) | 2016-06-01 | 2016-07-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330008133 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002164 | 330001214 | 1.94 | 65 | Curative (C) | 2015-03-16 | 2015-03-20 | CNS GCT II Non Germin - Std PEI | Y | N | 330008134 | NOT MATCHED |
| 330002165 | 330001215 | 0 | 80.4 | Curative (C) | 2017-09-02 | 2017-09-04 | null | 2 | null | 330008137 | NOT MATCHED |
| 330002166 | 330001216 | 1.7 | null | Neo-adjuvant (N) | 2014-01-22 | 2014-02-02 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 330008138 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002167 | 330001217 | null | 108 | Palliative (P) | 2014-06-07 | 2014-06-18 | null | Y | N | 330008139 | NOT MATCHED |
| 330002168 | 330001218 | null | 72.9 | Curative (C) | 2013-09-22 | 2013-10-09 | EW EuroEwing 2012 Arm B VDC | Y | N | 330008140 | TRIAL |
| 330002169 | 330001218 | null | 87.9 | Curative (C) | 2013-10-26 | 2013-11-23 | Cisplatin 7 day | N | Y | 330008140 | CISPLATIN |
| 330002170 | 330001218 | 0 | 92 | Curative (C) | 2013-03-25 | 2013-03-27 | EW EuroEwing 2012 Arm B VDC | Y | N | 330008140 | TRIAL |
| 330002171 | 330001218 | null | 9.7 | Curative (C) | 2013-09-07 | 2013-09-10 | NB HRNBL-1 TVD | null | N | 330008140 | NOT MATCHED |
| 330002172 | 330001218 | null | 19.8 | Curative (C) | 2013-10-31 | 2013-11-08 | NB HRNBL-1 BUMEL MAT | Y | Y | 330008140 | NOT MATCHED |
| 330002173 | 330001219 | 1.69 | null | null | 2017-12-07 | 2017-12-11 | EW EuroEwing 2012 Arm B VDC | N | 0 | 330008157 | TRIAL |
| 330002174 | 330001219 | null | 105.8 | Neo-adjuvant (N) | 2017-10-20 | 2017-10-20 | NB HRNBL-1 COJEC Ind COURSE A | Y | Y | 330008157 | NOT MATCHED |
| 330002175 | 330001219 | 1.71 | 10.75 | Neo-adjuvant (N) | 2013-03-21 | 2013-03-22 | Trial Unspecified | N | Y | 330008157 | TRIAL |
| 330002176 | 330001219 | 1.67 | 53.9 | Curative (C) | 2015-12-16 | 2015-12-20 | Trial Unspecified | 01 | null | 330008157 | TRIAL |
| 330002177 | 330001220 | null | 19.4 | Curative (C) | 2015-06-28 | 2015-07-06 | STS Rhabdo RMS 2005 | null | N | 330008162 | NOT MATCHED |
| 330002178 | 330001221 | 1.8 | 63.2 | Curative (C) | 2016-02-13 | 2016-03-10 | Cisplatin | N | Y | 330008175 | CISPLATIN |
| 330002179 | 330001222 | 1.84 | 151 | Palliative (P) | 2014-12-03 | 2014-12-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008177 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002180 | 330001223 | null | 101.2 | Palliative (P) | 2013-02-03 | 2013-02-17 | Trial Unspecified | null | N | 330008178 | TRIAL |
| 330002181 | 330001224 | null | 142 | Curative (C) | 2013-01-17 | 2013-09-21 | NB Low/Interm risk guidelines Carbo/Etop | Y | N | 330008180 | NOT MATCHED |
| 330002182 | 330001225 | null | 56.6 | null | 2017-05-07 | 2017-05-15 | Cisplatin 7 day | 02 | Y | 330008181 | CISPLATIN |